'Ireland Unaware of Consequences of Untreated Hearing Loss' - Mayo Advertiser

-

World Hearing Day, held on 3 March each year, aims to promote ear and hearing health and to raise awareness of how to prevent hearing loss.

According to Hidden Hearing Ireland CEO, Stephen Leddy, its latest global survey indicated a poor track record for the Irish when it comes to looking after their hearing health.

“Significant delays in the time taken by individuals to have their hearing tested and to seek treatment, were identified, combined with reluctance to use a hearing aid when needed”, he reported.

"22% in the Irish survey admitted waiting five years or more before seeking medical help for hearing loss. This was the highest figure in the global sample for treatment delay.

"Similarly, only 50% with hearing loss said they had a hearing test in the past three years and 35% did not have treatment, even when a problem was identified.

"Only 25% in the Irish survey, with mild to severe hearing loss, use hearing aids, whereas the global average is 51%. In countries like the USA and Australia, over 66% with hearing loss use hearing aids.

"In Ireland however, taking an eye test regularly, recorded at 67%, and wearing glasses or lenses, at 71%, were above the global averages of 53% and 61% respectively.

"While poor eyesight is something we refuse to live with in Ireland, it appears we Irish are more willing to suffer hearing loss", said Leddy.

Book a free hearing test in your local Hidden Hearing clinic and support World hearing Day on March 3. You can call 1800 882 884 to book into any Hidden Hearing Clinic nationwide. Also, you can visit online at hiddenhearing.ie



https://ift.tt/2Tt5dUG

Comments

Post a Comment

Popular posts from this blog

Well-liked Medicare plan vs. higher-ranked providers - ChicagoNow

-
Image
Medicare Open Enrollment ends December 7. The easy choice is to stay with all-in-one Medicare Advantage instead of switching to Traditional Medicare plus a supplement and drug plan. The hard one is whether to switch between Medicare Advantage plans, from a well-liked one to one accepted at a so-called top-10 hospital. Humana Gold Plus, a Medicare Advantage HMO, has served me well for five years. Hearing aids cost me only $10 after its $2,000 allowance. Routine doctor and dentist appointments and my medication cost nothing. But Humana Gold Plus is not accepted by Northwestern Memorial Hospital, the nearby hospital that US News & World Report ranks as the tenth best in the country, or by Northwestern Medicine physicians. My primary care physician is in an Advocate Medical Group. If I were hospitalized, it would be at Advocate Illinois Masonic Medical Center. If I had a serious illness, I’d see specialists in Advocate’s network. Illinois Masonic is not a second-rate hospital, and
Read more

Minnesota veterans blame 3M's 'defective' ear plugs for hearing damage - KSTP

-
Image
3M did not admit any wrongdoing as part of that settlement. Read 3M's full statement on the ear plugs here. "We deny this product was defectively designed," a company spokesperson said in a statement to 5 INVESTIGATES, adding they will "defend against the allegations in these lawsuits." More than 630 lawsuits have been filed and will be heard in a federal court in Florida. An attorney involved with the multi-district litigation says roughly 30 have been filed by veterans who live in Minnesota. Constant ringing Sarah Kay Carlson, an Army veteran from St. Paul, filed her lawsuit in April, claiming 3M exposed her and thousands of other Marines and soldiers to "extremely dangerous and disabling noise." 3M Earplug Complaint (Sarah Kay Carlson) Ramsey County (Filed) (PDF) 3M Earplug Complaint (Sarah Kay Carlson) Ramsey County (Filed) (Text) Carlson, who was deployed as part of Operation Iraqi Freedom in the late 2000s, provided security to convoys t
Read more

Sickle Cell Disease (SCD): Practice Essentials, Background, Genetics

-
Image
hemophilia c factor 11 :: Article Creator Regeneron Reports Fourth Quarter And Full Year 2023 Financial And Operating Results Fourth quarter 2023 revenues increased 1% to $3.43 billion versus fourth quarter 2022; excluding RonapreveTM(a)(b), revenuesincreased 14% Full year 2023 revenues increased 8% to $13.12 billion versus full year 2022;excluding Ronapreve(a), revenuesincreased 12% Fourth quarter 2023 Dupixent®global net sales(recorded by Sanofi) increased 31% to $3.22 billion versus fourth quarter 2022; full year 2023 Dupixent global net sales increased 33% to $11.59 billion versus 2022 Fourth quarter 2023 U.S. Net sales for EYLEA®HD and EYLEA®were $1.46 billion, including $123 million from EYLEA HD; full year 2023 U.S. Net sales for EYLEA HD and EYLEA were $5.89 billion, including $166 million from EYLEA HD following its August 2023 FDA approval Fourth quarter 2023 Libtayo®global n
Read more